Gemcitabine plus docetaxel for advanced or metastatic non-small cell lung cancer: Similar survival to cisplatin plus vinorelbine and less toxicity: Abstracted from: Pujol JL, Breton JL, Gervais R, et al. Gemcitabine–docetaxel versus cisplatin–vinorelbine in advanced or metastatic non-small-cell lung cancer: a phase III study addressing the case for cisplatin. Ann Oncol 2005;16:602–10.

✍ Scribed by Benjamin Solomon; Paul A. Bunn Jr.

• Book ID: 116394988
• Publisher: Elsevier Science
• Year: 2005
• Tongue: English
• Weight: 98 KB
• Volume: 31
• Category: Article
• ISSN: 0305-7372
• DOI: 10.1016/j.ctrv.2005.08.001